BrainStorm Cell Therapeutics
BCLI
#10410
Rank
C$8.5 M
Marketcap
C$0.77
Share price
0.00%
Change (1 day)
-62.60%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -C$16.01 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$16.01 Million, an increase over its 2023 earnings that were of -C$23.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$16.01 Million-0.02%
2024 -C$16.01 Million-32.39%
2023 -C$23.68 Million-29.18%
2022 -C$33.43 Million-0.74%
2021 -C$33.68 Million-23.12%
2020 -C$43.81 Million36.8%
2019 -C$32.02 Million66.71%
2018 -C$19.21 Million181.66%
2017 -C$6.82 Million-0.6%
2016 -C$6.86 Million-41.31%
2015 -C$11.69 Million-8.22%
2014 -C$12.74 Million89.74%
2013 -C$6.72 Million42.27%
2012 -C$4.72 Million-12.45%
2011 -C$5.39 Million63.04%
2010 -C$3.31 Million35.52%
2009 -C$2.44 Million-48.99%
2008 -C$4.79 Million-44.39%
2007 -C$8.6 Million
2005 -C$4.46 Million-91.44%
2004 -C$52.02 Million94007.62%
2003 -C$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$13.61 B-86,455.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-C$1.04 Billion 6,468.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-C$1.09 Billion 6,805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.62 B-16,731.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$28.45 M-280.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-C$0.36 Billion 2,131.73%๐Ÿ‡บ๐Ÿ‡ธ USA